Back to 
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
TRAX1 quarters
Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in FIRST TRACKS BIOTHERAPEUTICS
Yes. Arrowstreet Capital holds 299,500 shares of TRAX (First Tracks Biotherapeutics), worth $6M, as of its Q2 2026 13F filing.
Current Value
$6M
Current Shares
299,500
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of TRAX: FMR LLC, BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, Jupiter Topco LLC